Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate vs midazolam for ICU mechanical ventilation sedation
ChiCTR2200062622Phase 4Not yet recruiting
- Sponsor
- Hebei General Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (2 arms), sponsored by Hebei General Hospital. Primary endpoint: Mechanical ventilation time. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2200062622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062622.